Found: 11
Select item for more details and to access through your institution.
Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survivalof Thai post-menopausal breast cancer patientswho received adjuvant tamoxifen.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2013, v. 6, p. 37, doi. 10.2147/PGPM.S42330
- By:
- Publication type:
- Article
Lack of correlation between in silico projection of function and quantitative real-time PCR-determined gene expression levels in colon tissue.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2013, v. 6, p. 99
- By:
- Publication type:
- Article
Patient selection and targeted treatment in the management of platinum-resistant ovarian cancer.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2013, v. 6, p. 113, doi. 10.2147/PGPM.S24943
- By:
- Publication type:
- Article
Bosutinib: a SRC-ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2013, v. 6, p. 57, doi. 10.2147/PGPM.S32145
- By:
- Publication type:
- Article
Molecular targeted therapies in metastatic melanoma.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2013, v. 6, p. 49, doi. 10.2147/PGPM.S44800
- By:
- Publication type:
- Article
Delivering pharmacogenetic testing in a primary care setting.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2013, v. 6, p. 105, doi. 10.2147/pgpm.s50598
- By:
- Publication type:
- Article
Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategies.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2013, v. 6, p. 25, doi. 10.2147/PGPM.S26058
- By:
- Publication type:
- Article
Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2013, v. 6, p. 19, doi. 10.2147/PGPM.S36579
- By:
- Publication type:
- Article
Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
CORRIGENDUM.
- Published in:
- 2013
- Publication type:
- Correction Notice
GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2013, v. 6, p. 9, doi. 10.2147/PGPM.S35949
- By:
- Publication type:
- Article